![Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema | Science Translational Medicine Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.3008946/asset/b7c5be37-b8a9-4e25-84eb-f3ab815279a9/assets/graphic/6-244ra90-f3.jpeg)
Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema | Science Translational Medicine
![KIT PSORAXIL Specifico per la Cura della Psoriasi 100% Made in Italy - Doccia e Shampoo Attivo, Crema-Emulsione Viso Corpo e Integratore Alimentare : Amazon.it: Bellezza KIT PSORAXIL Specifico per la Cura della Psoriasi 100% Made in Italy - Doccia e Shampoo Attivo, Crema-Emulsione Viso Corpo e Integratore Alimentare : Amazon.it: Bellezza](https://m.media-amazon.com/images/I/61j6a8JURBL._AC_UF350,350_QL80_.jpg)
KIT PSORAXIL Specifico per la Cura della Psoriasi 100% Made in Italy - Doccia e Shampoo Attivo, Crema-Emulsione Viso Corpo e Integratore Alimentare : Amazon.it: Bellezza
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adver
![Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group - Journal of the American Academy of Dermatology Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group - Journal of the American Academy of Dermatology](https://www.jaad.org/cms/asset/6143fc67-122a-4ff7-bb7b-cca5c58f69aa/gr3.jpg)
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group - Journal of the American Academy of Dermatology
![Psoriasi: le terapie innovative hanno abbattuto non solo i costi di riduzione dei ricoveri, ma anche i rischi di complicanze - Motoresanità.it Psoriasi: le terapie innovative hanno abbattuto non solo i costi di riduzione dei ricoveri, ma anche i rischi di complicanze - Motoresanità.it](https://www.motoresanita.it/wordpress/wp-content/uploads/2022/09/24-11-psoriasi.jpg)
Psoriasi: le terapie innovative hanno abbattuto non solo i costi di riduzione dei ricoveri, ma anche i rischi di complicanze - Motoresanità.it
![PDF) Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis) PDF) Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)](https://www.researchgate.net/publication/372404786/figure/fig1/AS:11431281175081145@1689571217422/Clinical-effectiveness-of-brodalumab-throughout-156weeks-PASI-psoriasis-area-and_Q320.jpg)
PDF) Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
![KIT PSORAXIL Specifico per la Cura della Psoriasi 100% Made in Italy - Doccia e Shampoo Attivo, Crema-Emulsione Viso Corpo e Integratore Alimentare : Amazon.it: Bellezza KIT PSORAXIL Specifico per la Cura della Psoriasi 100% Made in Italy - Doccia e Shampoo Attivo, Crema-Emulsione Viso Corpo e Integratore Alimentare : Amazon.it: Bellezza](https://m.media-amazon.com/images/I/51LKgDlWVCL._SY350_PKmb-play-button-overlay_.jpg)
KIT PSORAXIL Specifico per la Cura della Psoriasi 100% Made in Italy - Doccia e Shampoo Attivo, Crema-Emulsione Viso Corpo e Integratore Alimentare : Amazon.it: Bellezza
![Psoriasi, perché i nuovi farmaci biologici non sono adatti a chi ha poche chiazze? | Psoriasi: le risposte ai vostri dubbi Psoriasi, perché i nuovi farmaci biologici non sono adatti a chi ha poche chiazze? | Psoriasi: le risposte ai vostri dubbi](https://psoriasi.corriere.it/files/2019/01/pillole-250x187.jpg)
Psoriasi, perché i nuovi farmaci biologici non sono adatti a chi ha poche chiazze? | Psoriasi: le risposte ai vostri dubbi
![Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: a 192 weeks multicentric retrospective study – IL PSO ( ITALIAN LANDSCAPE PSORIASIS ) | Request PDF Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: a 192 weeks multicentric retrospective study – IL PSO ( ITALIAN LANDSCAPE PSORIASIS ) | Request PDF](https://i1.rgstatic.net/publication/360972507_Real_life_long-term_efficacy_and_safety_of_ixekizumab_in_moderate-to-severe_psoriasis_a_192_weeks_multicentric_retrospective_study_-_IL_PSO_ITALIAN_LANDSCAPE_PSORIASIS/links/62a0d595416ec50bdb16734c/largepreview.png)
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: a 192 weeks multicentric retrospective study – IL PSO ( ITALIAN LANDSCAPE PSORIASIS ) | Request PDF
![PDF) Investigating psoriasis awareness among patients in Italy: validation of a questionnaire | Andrea Conti - Academia.edu PDF) Investigating psoriasis awareness among patients in Italy: validation of a questionnaire | Andrea Conti - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/44719032/mini_magick20190213-17980-cxblz8.png?1550124767)
PDF) Investigating psoriasis awareness among patients in Italy: validation of a questionnaire | Andrea Conti - Academia.edu
Psoriasis: gender perspective on disease characteristics and treatment | Journal of Sex- and Gender-Specific Medicine - Formerly The Italian Journal of Gender-Specific Medicine
![E' opportuno utilizzare i farmaci biologici la psoriasi durante l'emergenza COVID-19? - La Pelle SiCura E' opportuno utilizzare i farmaci biologici la psoriasi durante l'emergenza COVID-19? - La Pelle SiCura](https://lapellesicura.it/wp-content/uploads/2020/11/come-curare-la-psoriasi-stefano-veglio-dermatologo-cover.jpg)
E' opportuno utilizzare i farmaci biologici la psoriasi durante l'emergenza COVID-19? - La Pelle SiCura
![Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema | Science Translational Medicine Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema | Science Translational Medicine](https://www.science.org/cms/asset/3d794901-3280-4592-b02d-e579ee94049d/6-244ra90-f1.gif)
Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema | Science Translational Medicine
![Frontiers | The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway Frontiers | The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway](https://www.frontiersin.org/files/Articles/760852/fmed-09-760852-HTML/image_m/fmed-09-760852-g001.jpg)
Frontiers | The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway
![Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) - Narcisi - 2023 - Journal of the European Academy of Dermatology and Venereology - Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) - Narcisi - 2023 - Journal of the European Academy of Dermatology and Venereology -](https://onlinelibrary.wiley.com/cms/asset/955dd1f4-b3ef-46cd-a8e2-c81fbe99ca9a/jdv18594-fig-0002-m.jpg)
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) - Narcisi - 2023 - Journal of the European Academy of Dermatology and Venereology -
![Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) - Narcisi - 2023 - Journal of the European Academy of Dermatology and Venereology - Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) - Narcisi - 2023 - Journal of the European Academy of Dermatology and Venereology -](https://onlinelibrary.wiley.com/cms/asset/8cf3d75b-3392-4c2e-9b29-622570c0ec1b/jdv.v37.1.cover.jpg?trick=1689591455488)
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) - Narcisi - 2023 - Journal of the European Academy of Dermatology and Venereology -
![PDF) Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy PDF) Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy](https://i1.rgstatic.net/publication/315359256_Monitoring_treatment_response_in_psoriasis_current_perspectives_on_the_clinical_utility_of_reflectance_confocal_microscopy/links/5a73be7daca2720bc0dbd69a/largepreview.png)
PDF) Monitoring treatment response in psoriasis: current perspectives on the clinical utility of reflectance confocal microscopy
STAT3â•'dependent effects of ILâ•'22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibit
![Healthcare | Free Full-Text | Assessing Therapeutic Choices and Adherence to Antidiabetic Therapy in Naïve Patients: A Retrospective Observational Study in a Local Health Authority of the Piedmont Region ( Italy) Healthcare | Free Full-Text | Assessing Therapeutic Choices and Adherence to Antidiabetic Therapy in Naïve Patients: A Retrospective Observational Study in a Local Health Authority of the Piedmont Region ( Italy)](https://www.mdpi.com/healthcare/healthcare-11-01655/article_deploy/html/images/healthcare-11-01655-g001.png)